Evidence map›Paper›PMID 30469488›Full record

ArticleCancers2018

Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions.

Sourik S Ganguly, Paul G Daft, Jingchen Cao, Xiangqi Meng, Zhendong A Zhong, Alexandra Vander Ark, Austin Meadows, Zach Madaj, Bart Williams, Xiaohong Li

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sourik S GangulyProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. Sourik.Ganguly@vai.org.
Paul G DaftProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. paul.daft@gmail.com.
Jingchen CaoProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. jingchen.cao@vai.org.
Xiangqi MengProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. jzmxq@hotmail.com.
Zhendong A ZhongProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. alex.zhong@vai.org.
Alexandra Vander ArkProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. Alexandra.VanderArk@vai.org.
Austin MeadowsProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. meadowau@mail.gvsu.edu.
Zach MadajBioinformatics & biostatistics Core, Van Andel Research Institute, Grand Rapids, MI 49503, USA. Zachary.madaj@vai.org.
Bart WilliamsProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. bart.williams@vai.org.
Xiaohong LiProgram for Skeletal Disease and Tumor Microenvironment, Center for Cancer and Cell Biology, Grand Rapids, MI 49503, USA. xiaohong.li@vai.org.ORCID 0000-0001-5074-193X
Van Andel Institute · US

Funding

Van Andel Research Institute 53010A
6 · The paper itself

Abstract

The role of myeloid cell-specific TGF-β signaling in non-small-cell lung cancer (NSCLC)-induced osteolytic bone lesion development is unknown. We used a genetically engineered mouse model,

Indexed as

bFGFCTHRC1myeloid lineage cellsNSCLC bone metastasisosteoblastsosteoclastsTGFBR2TGF-β signalingWnt/β-catenin

Identifiers

PMID30469488
PMCPMC6315699
OpenAlexW2900616477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.